U.S. Stock News

NasdaqGS:AGYS
NasdaqGS:AGYSSoftware

Agilysys (AGYS) Is Up 13.8% After Unveiling 30+ New AI Features Across Hospitality Platforms

Agilysys, Inc. recently unveiled more than 30 new AI-powered features and software modules at its April 20–23, 2026 INSPIRE user conference, many of which are in early release and slated for initial customer deployments within about 90 days, while also announcing plans to release its fiscal 2026 fourth-quarter results on May 18, 2026. The breadth of these AI-native enhancements, spanning guest personalization, agentic automation, and revenue intelligence across its PMS, POS, and reservations...
NYSE:DFIN
NYSE:DFINCapital Markets

Is Donnelley Financial Solutions (DFIN) Pricing Look Attractive After Recent Share Price Weakness

Wondering if Donnelley Financial Solutions at around US$44 is offering value or just noise? This article breaks down what the current price might actually mean for you. The stock recently closed at US$44.21, with returns of a 12.1% decline over 7 days, a 10.0% decline over 30 days and a 3.1% decline year to date, alongside a 17.2% decline over 1 year, a 0.2% decline over 3 years and a 73.6% gain over 5 years. Recent coverage of Donnelley Financial Solutions has focused on its role in...
NYSE:FND
NYSE:FNDSpecialty Retail

A Look At Floor & Decor (FND) Valuation After Earnings, 2026 Guidance, Store Expansion And Buyback

Floor & Decor Holdings (FND) has come into focus after releasing first quarter results, issuing full year 2026 guidance, outlining plans for 20 new warehouse stores, and announcing a new US$400 million share repurchase program. See our latest analysis for Floor & Decor Holdings. The recent earnings release, new 2026 guidance, planned 20 warehouse openings and US$400 million buyback have coincided with short term momentum, with a 7 day share price return of 6.45% and 1 month share price return...
NasdaqGS:CGNT
NasdaqGS:CGNTSoftware

Why Cognyte Software (CGNT) Is Up 17.9% After Securing A US$20M AI Analytics Subscription Deal

Cognyte Software Ltd. previously announced a three-year subscription contract worth over US$20,000,000 with a long-standing EMEA-region customer, expanding deployment of its AI-driven analytics to handle higher data volumes and more complex investigations. The shift of this long-term relationship to a subscription model underscores recurring revenue visibility and deeper integration of Cognyte’s capabilities into mission-critical operations. Next, we’ll explore how this expanded, multi-year...
NYSE:AFL
NYSE:AFLInsurance

How Investors Are Reacting To Aflac (AFL) Earnings Miss Amid PFML Expansion And Capital Returns

Aflac Incorporated recently reported first-quarter 2026 results, with revenue rising to US$4.35 billion and net income to US$1.02 billion, while also continuing share repurchases, maintaining its quarterly dividend, and opening a new claims office in South Portland to support Maine’s Paid Family and Medical Leave program that began paying benefits on May 1. Despite this combination of earnings growth, capital returns, and expansion into state-administered leave programs, management...
NYSE:ACM
NYSE:ACMConstruction

Is AECOM (ACM) Pricing Reflect Its Value After Recent Share Price Weakness

If you are wondering whether AECOM's share price reflects its true value, you are not alone. This article focuses squarely on what the current price might be asking you to pay. The stock last closed at US$81.47, with returns of a 3.1% decline over 7 days, 2.2% decline over 30 days, 15.5% decline year to date and 21.1% decline over the past year, set against longer term returns of 7.8% over 3 years and 26.4% over 5 years. Recent coverage has centered on how investors are reassessing...
NYSE:ABBV
NYSE:ABBVBiotechs

Is AbbVie (ABBV) Still Worth Considering After Recent Share Price Pullback?

Investors may be wondering if AbbVie at around US$202 a share still offers value, or if most of the opportunity has already played out. The stock has recently seen mixed returns, with a 4.1% decline over the last 7 days, a 1.8% decline over 30 days, and an 11.6% decline year to date. Over 1 year and 5 years, the returns stand at 12.8% and 109.7% respectively. Recent headlines have focused on AbbVie's position in the large-cap pharmaceuticals space and how investors are weighing its long term...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

Is It Time To Revisit DraftKings (DKNG) After Recent Share Price Rebound

If you are trying to work out whether DraftKings stock looks attractively priced or too expensive at today’s levels, you will want more than just the latest share price in front of you. The stock recently closed at US$25.22, with returns of 8.1% over 7 days and 9.9% over 30 days, while year to date and 1 year returns of negative 29.3% and negative 28.7% show a very different picture over a longer window. Recent headlines around DraftKings have largely focused on the broader US sports betting...
NYSE:SEI
NYSE:SEIEnergy Services

Should SEI’s 600 MW Hyperscaler Deal and $1.3 Billion Notes Shape Solaris Energy Infrastructure Investors’ Plans?

In early May 2026, Solaris Energy Infrastructure’s subsidiary completed the pricing of US$1.30 billion of 6.375% senior unsecured notes due 2031, intended to refinance existing borrowings, cover fees and expenses, and support general corporate purposes including growth capital expenditures. This financing followed a strong first quarter 2026, when Solaris reported sharply higher revenue and net income and secured a new 10-year agreement to supply over 600 MW of power capacity and...
NYSE:TDG
NYSE:TDGAerospace & Defense

A Look At TransDigm Group’s Valuation After Recent Share Price Gains

Event context and recent stock performance TransDigm Group (TDG) stock has been on the move recently, with a roughly 7% gain over the past week. This adds to a month-long rise of about 6%, even as the past 3 months show a 3% decline. See our latest analysis for TransDigm Group. At a share price of $1,241.98, TransDigm Group’s recent 7 day and 30 day share price returns contrast with its weaker year to date move. The 3 year total shareholder return of 82.33% and 5 year total shareholder return...
NasdaqGS:BYND
NasdaqGS:BYNDFood

Assessing Beyond Meat (BYND) Valuation After Narrowing Q1 Losses And Softer Sales

Q1 results and new shelf registration Beyond Meat (BYND) has drawn fresh attention after reporting first quarter 2026 results, which showed a reduced net loss alongside lower sales. This was followed shortly by a US$10.4 million shelf registration tied to an employee stock ownership plan. See our latest analysis for Beyond Meat. The stock has moved sharply around the Q1 update and ESOP shelf filing, with a 30-day share price return of 53.93% contrasting with a 1-year total shareholder return...
NYSE:NU
NYSE:NUBanks

Is Nu Holdings (NU) Still Attractive After Recent Pullback And Strong Three Year Run?

Wondering if Nu Holdings is still good value at around US$14.26, or if the easy gains are already behind it? This overview sets you up to judge the stock price with a clear, structured lens. The stock has returned 11.4% over the last year and a very large 3 year gain, even as the year to date move sits at a 16.2% decline, which can change how the market views both its growth potential and risk. Recent headlines have focused on Nu Holdings as a large listed Latin American digital bank, often...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

Zoetis Resets Outlook As U.S. Pet Weakness Pressures Valuation And Growth

Zoetis (NYSE:ZTS) has cut its full year guidance after a sharp downturn in its U.S. companion animal business. Management points to higher price sensitivity among pet owners, fewer veterinary visits, and more generic competition as key pressures. The company is refocusing on integrated solutions, tighter cost controls, and operational efficiency as part of a broad reset. For investors, the reset lands on top of a steep share price pullback. Zoetis now trades at $87.31, with the stock down...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Is It Too Late To Consider Krystal Biotech (KRYS) After Its Strong Share Price Run?

For investors wondering if Krystal Biotech at around US$296.70 is still offering value or if the easy gains are behind it, this article walks through what the current price may be implying. The stock has shown strong share price moves, with returns of 13.1% over 7 days, 12.4% over 30 days, 20.2% year to date, 116.3% over the last year, 228.5% over 3 years, and 374.4% over 5 years. These price moves sit against a backdrop of ongoing attention on Krystal Biotech's position in the...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Pharmaceutical (RARE) Is Up 5.8% After Reaffirming 2026 Outlook Despite Wider Losses – What's Changed

Ultragenyx Pharmaceutical Inc. reported past first-quarter 2026 results with revenue of US$136 million, a wider net loss of US$185 million, and reaffirmed its 2026 revenue guidance of US$730 million to US$760 million while remaining on a stated path toward profitability in 2027. Management also highlighted potential 2026 approvals for two gene therapies and key late-stage data for its Angelman syndrome program, underscoring how clinical and regulatory milestones are central to its...
NYSE:AXP
NYSE:AXPConsumer Finance

American Express Satisfaction Streak Supports Premium Brand And Valuation Story

American Express was ranked #1 in U.S. Credit Card Customer Satisfaction in the 2025 JD Power Study. This is the sixth consecutive year the company has taken the top spot. The study highlights especially strong satisfaction for premium and fee-based cardholders. The recognition comes as American Express refreshes benefits on its Gold Card product. For investors watching NYSE:AXP, this recognition adds another data point to the company’s premium brand story. The stock is trading at $318.69,...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Gibraltar Industries (ROCK) Margin Compression And Q1 EPS Loss Test Bullish Growth Narrative

Gibraltar Industries (ROCK) opened Q1 2026 with total revenue of US$356.3 million and a basic EPS loss of US$0.40, setting a cautious tone around the latest numbers. The company has seen quarterly revenue move from US$246.4 million and EPS of US$0.76 in Q1 2025 through a series of US$309.5 million to US$310.9 million quarters with EPS between US$0.99 and US$1.12, before landing at US$268.7 million and EPS of US$0.40 in Q4 2025. This gives investors a clear look at how the top line has...
NYSE:MTG
NYSE:MTGDiversified Financial

How Investors Are Reacting To MGIC Investment (MTG) Q1 Revenue Dip With Stable EPS

MGIC Investment Corporation recently reported its first-quarter 2026 results, with revenue of US$297.08 million and net income of US$165.3 million, both lower than the same period a year earlier. Despite the revenue and profit declines, MGIC’s basic and diluted earnings per share from continuing operations held around US$0.76, indicating stable per-share profitability even as overall earnings softened. Now we’ll examine how this combination of lower revenue but steady earnings per share...
NYSE:ALB
NYSE:ALBChemicals

The Bull Case For Albemarle (ALB) Could Change Following Q1 Earnings Beat And Balance Sheet Gains – Learn Why

Albemarle Corporation recently reported first-quarter 2026 results, with sales rising to US$1,428.73 million and net income increasing to US$319.09 million, alongside basic earnings per share from continuing operations of US$2.35 and a quarterly dividend of US$0.405 per share payable on July 1, 2026. The quarter’s outcome was underpinned by much stronger pricing and volume in the Energy Storage and Specialties segments, together with debt reduction funded by divestitures that strengthened...
NasdaqCM:SGML
NasdaqCM:SGMLMetals and Mining

Is It Too Late To Consider Sigma Lithium (SGML) After Its Strong 1 Year Rally?

Wondering if Sigma Lithium's current share price reflects its true worth, or if the recent excitement has run ahead of the fundamentals? The stock last closed at US$23.65, with returns of 7.2% over 7 days, 61.7% over 30 days, 66.4% year to date, 218.7% over 1 year and 401.5% over 5 years, while the 3 year return stands at a loss of 40.0%. Recent coverage has focused on Sigma Lithium as a lithium producer, with investors watching how sentiment around the sector and the company's development...
NYSE:ES
NYSE:ESElectric Utilities

Eversource Energy (ES) Earnings Surge And Margin Expansion Test Long Term Bearish Narratives

Eversource Energy (ES) opened 2026 with Q1 revenue of about US$4.5 billion and basic EPS of US$1.61, setting the stage against a year of sharply higher trailing earnings and wider margins. Over the last six reported quarters, quarterly revenue has ranged from US$2.8 billion to US$4.5 billion while basic EPS has moved between roughly US$0.20 and US$1.61, and on a trailing twelve month basis EPS reached US$4.69 alongside revenue of about US$13.9 billion. With trailing net margin sitting above...
NYSE:SAH
NYSE:SAHSpecialty Retail

Will Sonic Automotive's (SAH) Dividend Hike and ESOP Share Shelf Change Its Capital Allocation Narrative

In late April 2026, Sonic Automotive reported first-quarter 2026 results showing revenue of US$3,688.5 million, net income of US$60.8 million, and diluted EPS of US$1.79, while also announcing a higher quarterly dividend of US$0.4100 per share and continued progress on a long-running share repurchase program. Just days later, Sonic Automotive filed a US$151.18 million shelf registration for 2,000,000 Class A shares tied to its ESOP, underscoring how capital returns and employee ownership are...
NasdaqGS:WMT
NasdaqGS:WMTConsumer Retailing

Is It Too Late To Consider Walmart (WMT) After A 34.8% One Year Share Price Jump?

If you are wondering whether Walmart's share price still offers value after a strong run, the key is understanding how its current market price compares to what the business might reasonably be worth. At a last close of US$130.20, Walmart's stock has a 1 week return of a 1.3% decline, a 30 day return of 6.3%, a year to date return of 15.5%, a 1 year return of 34.8% and a 3 year return that is described as very large. The question is whether today's price still stacks up against the...
NYSE:NABL
NYSE:NABLSoftware

N Able (NABL) Q1 Revenue Growth Tests Profitability Turnaround Narratives

N-able (NABL) has opened 2026 with Q1 revenue of US$133.7 million and a basic EPS loss of US$0.00, alongside net income excluding extraordinary items of a US$0.6 million loss, setting a mixed tone for the latest results. Over recent quarters the company has seen revenue move from US$118.2 million in Q1 2025 to US$133.7 million in Q1 2026, while basic EPS has shifted between a profit of US$0.01 in Q3 2025 and a larger loss of US$0.04 in Q4 2025 before this latest small loss per share. For...